CD8A and neoplasm: The concentration of butyric acid, one of the most concerned beneficial SCFA for stimulating CD8+ T cells, in the fecal samples of the SCXN group was 3.53 and 3.27 times of those in the saline and Cap groups, respectively, which contributed to the enhanced anti-tumor immunity.